Calcium and vitamin D supplements provide little to no meaningful protection against bone fractures or falls in older adults, according to a major systematic review and meta-analysis published on September 27, 2026, in The BMJ. Led by clinical pharmacist Olivier Massé at the Integrated University Health and Social Services Center of North Montreal Island (CIUSSS), researchers evaluated 69 randomized trials involving more than 150,000 participants and concluded that routine supplementation is not supported by the evidence.
Evaluating 69 Trials on Bone Health Supplements
To determine if common nutritional supplements safeguard skeletal integrity, researchers gathered data from 69 trials encompassing 153,902 adult participants. The team assessed whether calcium, vitamin D, or a combination of both reduced the frequency of fractures or falls compared to a placebo or no treatment. Using moderate-to-high certainty evidence, the analysis revealed that individual or combined regimens had virtually no effect on overall fracture rates.
According to the findings, calcium supplementation data was drawn from 11 trials involving 9,067 participants at a moderate certainty level. Vitamin D evaluation relied on high certainty evidence from 36 trials with 92,045 participants. Combined calcium and vitamin D assessment utilized high certainty evidence across 15 trials featuring 51,126 individuals. In nearly all categories, researchers found no clinically meaningful reduction in fragility fractures or falls.
Weighing Costs and Potential Harms of Calcium and Vitamin D
Fragility fractures represent the primary clinical consequence of osteoporosis, a degenerative condition characterized by weak and brittle bones. Medical professionals have traditionally advised at-risk patients to consume vitamin D and calcium to aid bone mineralization and intestinal absorption. However, the new review highlights that these interventions may impose unnecessary healthcare costs while yielding minimal physiological return.
Did You Know? Estimates suggest that treating all adults aged 50 and older with osteoporosis in the United States and the European Union with calcium and vitamin D supplements costs approximately $2 billion annually. Meanwhile, calcium products frequently trigger gastrointestinal side effects such as constipation, bloating, abdominal pain, and cramps.
Three independent Canadian researchers who authored an accompanying editorial agreed that clear evidence of clinical effectiveness is lacking. They noted that given the absence of verified benefits, the potential for gastrointestinal harm from calcium, and substantial system-wide costs, routine recommendations for high-risk populations should be reconsidered.
Historical Context of Supplement Guidelines
Clinical guidelines continue to promote these nutrients despite shifting trial results over the past three decades. A recent systematic review of 34 health guidelines indicated that 70 percent recommended or suggested vitamin D supplements for fracture prevention or general health. This practice traces back to the 1990s, when initial major trials demonstrated a reduction in fractures over three years among individuals taking vitamin D and calcium together.
Subsequent investigations failed to replicate those early outcomes. Although systematic reviews in the early 2000s suggested potential benefits, those publications relied on small participant pools, and one significant trial from that era was later retracted. More recent evaluations have repeatedly failed to substantiate a direct link between vitamin D supplementation and lower fracture incidence.
Exceptions for Deficiencies and Specific Treatments
The authors of the review emphasize that their conclusions do not apply to everyone uniformly. Individuals diagnosed with severe vitamin D deficiencies may still experience therapeutic benefits from supplementation. The analysis excluded patients undergoing active pharmacological treatment for osteoporosis and included very few trials focused on severe deficiency.
Researchers confirmed that the core findings remained consistent across various subgroup analyses, including patient age, sex, baseline calcium intake from food, previous falls, and prior fracture history. Consequently, the authors argue that broad, population-wide recommendations for vitamin D monotherapy are scientifically unjustified.
Study finds calcium and vitamin D supplements fail to prevent fractures
Do calcium and vitamin D supplements prevent fractures in older adults?
No. A systematic review and meta-analysis of 69 trials published in The BMJ found that calcium, vitamin D, or combined supplements provide little to no meaningful protection against fractures or falls.
Who led the recent meta-analysis published in The BMJ?
The research team was led by Olivier Massé, a clinical pharmacist at the Integrated University Health and Social Services Center of North Montreal Island (CIUSSS).
Are there any side effects associated with calcium supplements?
Yes. Calcium supplementation can cause gastrointestinal complications, including constipation, bloating, abdominal pain, and cramps.
Do these findings apply to people with severe vitamin D deficiencies or osteoporosis medication?
No. The study excluded patients receiving drug treatment for osteoporosis and included very few trials involving severe vitamin D deficiency, meaning those specific groups require individualized medical evaluation.